Intellectual Property

Intellectual Property - China

Our lawyers solve your most significant intellectual property challenges

At King & Wood Mallesons, we make it our business to understand the value of our clients’ intellectual property.

The difference lies at the heart of our approach. We believe that in a world where many things look and feel the same, how you make your mark is what truly defines you. With innovation and marketing the new battlegrounds, safeguarding your creativity and projecting your innovations helps you develop your brand.

With rapid economic and scientific development shaping the commercial landscape in China, protecting ideas and innovation is the key to safeguarding China’s market competitiveness and an emerging generation of entrepreneurs. Offering strategic commercial solutions and an enviable track record in disputes, we work with you to solve your most significant challenges across patent, trademark, intellectual property (IP) legal and IP litigation.

Advising the biggest brands on IP law

Major brand owners and corporate giants make up a loyal group of clients that we advise across contentious and non-contentious IP. This experience working with some of the biggest and most ambitious brands around means we understand that you want sound professional judgment, not just equivocation, and advice based on your commercial drivers, not just the best legal solution. We thrive on working with you and on finding solutions to your most complex problems.

Our clients include corporate giants in the telecommunications, media, entertainment and technology (TMET) sectors such as Microsoft, Nokia, IBM, Sony, and BSkyB. Major brand owners from all sectors also benefit from our advice. Our clients include Siemens, Bosch, Emerson, Accor Hotels, adidas, Amazon, eBay, Starbucks, Stolichnaya Vodka, Westfield, Lonely Planet, Autumnpaper Limited (owner of the Alexander McQueen brands), Basuch & Lomb, bet365, Breitling, E! Entertainment, Nintendo, and Polo Ralph Lauren. And away from the TMET sector, we advise pharmaceutical and healthcare clients such as Actavis, Lupin, NicOx, Ranbaxy, Sanofi-Aventis, and Zentiva.

Our services in intellectual property law cover:

Our law firm’s experience of intellectual property work in China includes advising:

  • The 29th Olympic Games Organizing Committee and Samsung (China) Investment Ltd in the dispute over the Olympic slogan ‘One World, One Dream’, obtaining a favourable outcome for the clients
  • As the sole independent evaluator of whether the submitted Chinese Patents qualified as “essential patents” by Blu-ray Disc format standards, and were therefore eligible to be included in the patent pool licensing programme
  • As the sole independent evaluator on the “essential patents” for the industry standard relating to the next generation video coding, also known as HEAVC or H.265, in connection with a licensing program administered by MPEG LA
  • Guangzhou Pharmaceutical Group (best-known as the manufacturer of Wanglaoji herbal tea) versus JDB Group (a Hong Kong-based manufacturer of beverages) in a lawsuit for false advertising, trademark infringement and claim for RMB10 million in compensation, in which we obtained a favourable outcome for our client.
"They are definitely a top firm: a comprehensive team filled with high-quality lawyers."

Intellectual Property/Chambers

Read our in-depth analysis of the issues affecting IP in China Law Insight.

Discover our latest insights into legal issues affecting your business

The judgment was detailed and set standards regarding trademarks using the names of foreign countries.

09 November 2017

What are the challenges under accelerated enforcement of the new patent linkage system in China?

31 October 2017

In severe infringement cases, an action may even be brought by the IP owner in the criminal court.

11 August 2017

How to prevent inadvertent copyright infringement on your enterprise social media accounts?

19 July 2017

Your business sector

Discover our global sector experience relating to this practice

This publication has been downloaded from the King & Wood Mallesons website. It is provided only for your information and does not constitute legal or other advice on any specific matter. If you require or seek legal advice you should obtain such advice from your own lawyer, and should do so before taking, or refraining from taking, any action in reliance on this publication. If you have any questions, please contact King & Wood Mallesons. See www.kwm.com for more information.